These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 23540593

  • 1. Rituximab in the treatment of primary cutaneous B-cell lymphoma: a review.
    Fernández-Guarino M, Ortiz-Romero PL, Fernández-Misa R, Montalbán C.
    Actas Dermosifiliogr; 2014 Jun; 105(5):438-45. PubMed ID: 23540593
    [Abstract] [Full Text] [Related]

  • 2. Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.
    Fabbri A, Cencini E, Alterini R, Rubegni P, Rigacci L, Delfino C, Puccini B, Fimiani M, Bosi A, Bocchia M, Pimpinelli N, Gruppo Italiano Linfomi Cutanei (GILC).
    Eur J Haematol; 2014 Aug; 93(2):129-36. PubMed ID: 24635751
    [Abstract] [Full Text] [Related]

  • 3. Spontaneous regression of primary diffuse large B-cell lymphoma, leg type.
    Alcántara-González J, González-García C, Fernández-Guarino M, Jaén-Olasolo P.
    Actas Dermosifiliogr; 2014 Aug; 105(1):78-83. PubMed ID: 23098572
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome of intravenous therapy with rituximab in patients with primary cutaneous B-cell lymphomas.
    Brandenburg A, Humme D, Terhorst D, Gellrich S, Sterry W, Beyer M.
    Br J Dermatol; 2013 Nov; 169(5):1126-32. PubMed ID: 23796422
    [Abstract] [Full Text] [Related]

  • 5. [Cutaneous follicular center B-cell lymphoma treated with intralesional rituximab].
    Gamo R, Calzado L, Pinedo F, López-Estebaranz JL.
    Actas Dermosifiliogr; 2008 May; 99(4):291-6. PubMed ID: 18394405
    [Abstract] [Full Text] [Related]

  • 6. Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature review.
    Brunet-Possenti F, Franck N, Tamburini J, Jacobelli S, Avril MF, Dupin N.
    Dermatology; 2011 May; 223(3):200-2. PubMed ID: 21986026
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
    Kerl K, Prins C, Saurat JH, French LE.
    Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
    [Abstract] [Full Text] [Related]

  • 12. Rituximab in cutaneous B-cell lymphoma: a report of two cases.
    Sabroe RA, Child FJ, Woolford AJ, Spittle MF, Russell-Jones R.
    Br J Dermatol; 2000 Jul; 143(1):157-61. PubMed ID: 10886152
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cutaneous B-cell lymphoma treatment with rituximab: two cases].
    Viguier M, Bachelez H, Brice P, Rivet J, Dubertret L.
    Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1152-5. PubMed ID: 12442128
    [Abstract] [Full Text] [Related]

  • 15. Treatment of primary cutaneous follicular centre lymphoma with rituximab: a report of two cases.
    Kennedy GA, Blum R, McCormack C, Prince HM.
    Australas J Dermatol; 2004 Feb; 45(1):34-7. PubMed ID: 14961906
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group].
    Grange F, D'Incan M, Ortonne N, Dalac S, Laroche L, Beylot-Barry M, Delfau-Larue MH, Vergier B, Bagot M, pour le Groupe français d’étude des lymphomes cutanés.
    Ann Dermatol Venereol; 2010 Feb; 137(8-9):523-31. PubMed ID: 20804896
    [Abstract] [Full Text] [Related]

  • 19. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma.
    Heinzerling LM, Urbanek M, Funk JO, Peker S, Bleck O, Neuber K, Burg G, von Den Driesch P, Dummer R.
    Cancer; 2000 Oct 15; 89(8):1835-44. PubMed ID: 11042581
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.